X

Roivant Sciences (ROIV) Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna

Roivant Sciences (NASDAQ: ROIV) FY 2026 Other Release

Newsdesk: